A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer (Q35835203)
Jump to navigation
Jump to search
scientific article published on 14 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer |
scientific article published on 14 February 2012 |
Statements
1 reference
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer (English)
1 reference
A A Chiappori
1 reference
M T Schreeder
1 reference
M M Moezi
1 reference
J J Stephenson
1 reference
J Blakely
1 reference
R Salgia
1 reference
Q S Chu
1 reference
H J Ross
1 reference
D S Subramaniam
1 reference
J Schnyder
1 reference
M S Berger
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference